GABRIELA BAIDA: Open Payments
NPI 1568959153 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 9 payments from 6 companies in 2025. Trend: 2023 $416 · 2024 $303 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| KYOWA KIRIN, INC. | 1 | $122 |
| Alexion Pharmaceuticals, Inc. | 1 | $115 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: COBENFY, UZEDY, Auvelity, FANAPT.
Industry payments across TX — which companies pay providers there.
